Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety, Efficacy and Pharmacokinetics of OPC-67683 in Patients With Pulmonary Tuberculosis
This study has been completed.
Study NCT00401271.   Last updated on March 6, 2007.
Information provided by Otsuka Frankfurt Research Institute GmbH
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pulmonary Tuberculosis
Additional conditions recognized in this trial
Tuberculosis
Tuberculosis, Pulmonary
More general conditions related to this trial
Actinomycetales Infections
Bacterial Infections
Gram-Positive Bacterial Infections
Lung Diseases
Mycobacterium Infections
Respiratory Tract Diseases
Respiratory Tract Infections
Interventions listed in this trial
OPC-67683
Rifafour e-275
Sponsors listed in this trial
Otsuka Frankfurt Research Institute GmbH


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services